The FDA has cleared the first app that integrates glucose data with multiple daily injection (MDI) insulin dosing for people with diabetes.

The FDA has granted 510(k) clearance to Medtronic for its MiniMed “Go Smart” multiple daily injection system — the first ...

The global diabetes injection pens market is projected to grow at a CAGR of approximately 7% through 2028. Market expansion ...

A real-world study conducted across 9 European countries found that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among ...

A major challenge for people who have a form of diabetes is the need to regulate the glucose levels in their body. Normally this is where the body’s insulin-producing cells would respond to glucose ...

People with type I diabetes have to inject themselves multiple times a day with manufactured insulin to maintain healthy levels of the hormone, as their bodies do not naturally produce enough. The ...

Diabetic patients are often advised insulin therapy. But taking multiple injections daily may feel like a nightmare for many.

This form of rapid-acting inhaled insulin, recently introduced in India by the name Afrezza, is said to offer an important ...

Repeated insulin shots at the same site can seed amyloid; consider this diagnosis if absorption seems erratic or glucose control worsens with a persistent lump.

Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...

Tests in animals show the material works like the body's own system. Post content hidden for low score. Show… Post content hidden for low score. Show… Seems like a pretty interesting idea. I know a ...